|
Anti-HIV gp120 IgG (poly) IgG |
AB-16150 |
100 ul |
ALPHA DIAGNOSTICS |
|
|
|
|
Anti-HIV gp41 IgG (poly) |
AB-16160 |
100 ul |
ALPHA DIAGNOSTICS |
|
|
|
|
Anti-HIV p24 IgG (poly) |
AB-16140 |
100 ul |
ALPHA DIAGNOSTICS |
|
|
|
|
anti-HIV protease antibody [1696] |
ARG63002 |
100 ug |
ARIGO |
|
|
|
|
anti-HIV protease antibody [1696] (azide free) |
ARG63001 |
100 ug |
ARIGO |
|
|
|
|
Anti-HIV Virus/Virion IgG (poly) |
AB-16130 |
100 ul |
ALPHA DIAGNOSTICS |
|
|
|
|
Anti-HIV-1 gp41 IgG |
AB-16010 |
1 ml |
ALPHA DIAGNOSTICS |
|
|
|
|
Anti-HIV-2 gp39 IgG |
AB-16110 |
1 ml |
ALPHA DIAGNOSTICS |
|
|
|
|
anti-HIV1 p24 antibody |
ARG22688 |
1 ml |
ARIGO |
|
|
|
|
anti-HIV1 p24 antibody [473] |
ARG10061 |
100 ug |
ARIGO |
|
|
|
|
anti-HIV1 p24 antibody [473] (HRP) |
ARG10168 |
0.2 ml |
ARIGO |
|
|
|
|
anti-HIV1 P24 Core Protein antibody [340] |
ARG10167 |
500 ug |
ARIGO |
|
|
|
|
Mouse Anti- HIV-1 p24 IgG |
AB-15210 |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Mouse Anti-HIV-1 gp120 (PND, principal neutralizing domain) IgG |
AB-15110 |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Mouse Anti-HIV-1 gp41 IgG |
AB-15910 |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Mouse Anti-HIV-2 gp39 IgG |
AB-15310 |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Rabbit anti-HIV-1 nef antibody |
HIV11-S |
100 ul |
ALPHA DIAGNOSTICS |
|
|
|
|
Rabbit anti-HIV-1 p24 antibody |
HIV21-S |
100 ul |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E. coli) HIV gp13 protein (HIV-gp13 Subtype O), soluble |
HGP13-R |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E. coli) HIV gp36 protein (soluble) |
HGP362-R |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E. coli) HIV Protease Protein (9-aa, His-tag, ~12 kda, <95%) |
RP-1633 |
5 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E. coli) HIV-1 gp41 protein (gp41 epitopes+gp120 CT, soluble) |
HGP412-R |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E. coli) HIV-1 gp41 protein (insoluble) |
HGP410-R |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E. coli) HIV-1 gp41, protein (soluble) |
HGP411-R |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E. coli) HIV-1 p120 protein (C-terminus of gp120 and most of gp41) (soluble ~16 kda) |
HP1201-R |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E. coli) HIV-1 p24 core (full length, GST at the NT, >90%, His-Tag) |
RP-583-7 |
25 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E. coli) HIV-1 p24 gag (155-321aa, His-tag at the NT, >95%) |
RP-583-8 |
20 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E. coli) HIV-1 p24 gag (group M, subtype B, strain 92418, 133-363 aa) (27 kda, >95%, His-Tag) |
RP-583-1 |
50 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E. coli) HIV-1 p24 gag (group M, subtype B, strain HXB2, 133-363 aa) (27 kda, >95%, His-Tag) |
RP-583-2 |
50 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E. coli) HIV-1 p24 gag (group M, subtype C, strain 92BR025, 131-363 aa) (27 kda, >95%, His-Tag) |
RP-583-5 |
50 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E. coli) HIV-1 p24 gag (group M, subtype D, strain NDK, 131-363 aa) (27 kda, >95%, His-Tag) |
RP-583-4 |
50 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E. coli) HIV-1 p24 gag (group N, strain 06CM-U14296, 131-363 aa) (27 kda, >95%, His-Tag) |
RP-583-6 |
50 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E. coli) HIV-1 p24 gag (group O, strain BCF06, 131-362 aa) (27 kda, >95%, His Tag) |
RP-583-3 |
50 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E.Coli) HIV Type-O Envelope |
RP-565 |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E.Coli) HIV Type-O gp41 |
RP-567 |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E.Coli) HIV-1 Envelope ( 233) |
RP-533 |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E.Coli) HIV-1 Envelope conjugated to HIV-2 gp39 |
RP-564 |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E.Coli) HIV-1 gag p17, p24, gp120 proteins, GST at the NT (>95%) |
RP-543 |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E.Coli) HIV-1 gag p17-p24, gp41-gp120 (>95%) |
RP-542 |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E.Coli) HIV-1 gp41 (HIV gp41, 288 aa, 466-753-betal gal fusion protein) |
RP-544 |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E.Coli) HIV-1 gp41 Long (444-833 aa gp41+Beta-Gal at NT, 114 Kda) |
RP-545 |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E.Coli) HIV-1 gp41 Long, Biotin Labeled |
RP-552 |
50 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E.Coli) HIV-1 gp41 Long, Horseradish peroxidase Labeled |
RP-553 |
50 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E.Coli) HIV-1 gp41, Biotin Labeled |
RP-550 |
50 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E.Coli) HIV-1 gp41, Horseradish Peroxidase Labeled |
RP-551 |
50 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E.Coli) HIV-1 nef |
RP-557 |
100 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E.Coli) HIV-1 p24 immunodominant regions (>95%) , HRP Labeled |
RP-541 |
50 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E.Coli) HIV-1 TAT |
RP-562 |
10 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E.Coli) HIV-1 TAT Clade-C |
RP-549 |
10 ug |
ALPHA DIAGNOSTICS |
|
|
|
|
Recombinant (E.Coli) HIV-1 TAT, Biotin Labeled |
RP-561 |
1 ug |
ALPHA DIAGNOSTICS |
|
|
|